References
- Wohrer A, Waldhor T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mosenbacher U, et al. The Austrian Brain Tumor Registry: A cooperative way to establish a population-based brain tumour registry. J Neurooncol 2009;95:401–11.
- Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, et al. Descriptive epidemiology of CNS tumors in France: Results from the Gironde Registry for the period 2000–2007. Neuro Oncol 2011;13:1370–8.
- Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 2012;14(Suppl 5):v1–49.
- Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973–1993. J Neurooncol 2002;60:61–9.
- Ronning PA, Helseth E, Meling TR, Johannesen TB. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro Oncol 2012;14:1178–84.
- Sehmer EA, Hall GJ, Greenberg DC, O’Hara C, Wallingford SC, Wright KA, et al. Incidence of glioma in a northwestern region of England, 2006–2010. Neuro Oncol 2014;16:971–4.
- Asklund T, Malmström A, Björ O, Blomquist E, Henriksson R. Considerable improvement in survival for patients aged 60–84 years with high-grade malignant gliomas – data from the Swedish Brain Tumour Population-based Registry. Acta Oncol 2013;52:1041–3.
- Asklund T, Björ O, Malmström A, Blomquist E, Henriksson R.[Survival in malignant gliomas has increased the last decade. Analysis of quality data]. [Article in Swedish]. Läkartidningen 2012;109:875–8.
- Bergenheim T, Malmström A, Bolander H, Michanek A, Stragliotto G, Damber L, et al. [Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. [Article in Swedish]. Läkartidningen 2007;104:332–8, 340–1.
- Clarke JL, Chang SM. Neuroimaging: Diagnosis and response assessment in glioblastoma. Cancer J 2012;18:26–31.
- Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007;85:339–43.
- Lawrence YR, Blumenthal DT, Matceyevsky D, Kanner AA, Bokstein F, Corn BW. Delayed initiation of radiotherapy for glioblastoma: How important is it to push to the front (or the back) of the line? J Neurooncol 2011;105:1–7.
- Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, et al. Extent of resection in patients with glioblastoma: Limiting factors, perception of resectability, and effect on survival. J Neurosurg 2012;117:851–9.
- Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2014;115:3–8.
- Weller M, Bent M, Hopkins K, Tonn JC, Stupp R, Henriksson R, et al for the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncology 2014;15: e395–403.
- Henriksson R, Asklund T, Poulsen HS. Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastomamultiforme: A review. J Neurooncol 2011;104: 639–46.